Patents by Inventor Alberto Bryan

Alberto Bryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10167326
    Abstract: The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN], AFPep, that has anti-estrotrophic activity. The analogs of the invention include peptides and peptidomimetics that inhibit estrogen receptor-dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: January 1, 2019
    Assignee: ALBANY MEDICAL COLLEGE
    Inventors: Thomas T. Andersen, Herbert I. Jacobson, James A. Bennett, Leroy Joseph, Alberto Bryan
  • Publication number: 20160222074
    Abstract: The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN], AFPep, that has anti-estrotrophic activity. The analogs of the invention include peptides and peptidomimetics that inhibit estrogen receptor-dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Applicant: ALBANY MEDICAL COLLEGE
    Inventors: Thomas T. ANDERSEN, Herbert I. JACOBSON, James A. BENNETT, Leroy JOSEPH, Alberto BRYAN
  • Patent number: 9249189
    Abstract: The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN] (SEQ ID NO: 13), AFPep, that has anti-estrotrophic activity. The analogs of the invention include peptides and peptidomimetics that inhibit estrogen receptor-dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: February 2, 2016
    Assignee: ALBANY MEDICAL COLLEGE
    Inventors: Thomas T. Andersen, Herbert I. Jacobson, James A. Bennett, Leroy Joseph, Alberto Bryan
  • Publication number: 20130059794
    Abstract: The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN], AFPep, that has anti-estrotrophic activity. The analogs of the invention include peptides and peptidomimetics that inhibit estrogen receptor-dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
    Type: Application
    Filed: January 18, 2011
    Publication date: March 7, 2013
    Applicant: ALBANY MEDICAL COLLEGE
    Inventors: Thomas T. Andersen, Herbert I. Jacobson, James A. Bennett, Leroy Joseph, Alberto Bryan